| Id |
Subject |
Object |
Predicate |
Lexical cue |
| TextSentencer_T1 |
0-123 |
Sentence |
denotes |
Differences in the contribution of the CTLA4 gene to susceptibility to fulminant and type 1A diabetes in Japanese patients. |
| T1 |
0-123 |
Sentence |
denotes |
Differences in the contribution of the CTLA4 gene to susceptibility to fulminant and type 1A diabetes in Japanese patients. |
| TextSentencer_T2 |
124-134 |
Sentence |
denotes |
OBJECTIVE: |
| T2 |
124-134 |
Sentence |
denotes |
OBJECTIVE: |
| TextSentencer_T3 |
135-277 |
Sentence |
denotes |
To examine the contribution of the CTLA4 gene in the susceptibility to fulminant type 1 diabetes and compare it with classic type 1A diabetes. |
| T3 |
135-277 |
Sentence |
denotes |
To examine the contribution of the CTLA4 gene in the susceptibility to fulminant type 1 diabetes and compare it with classic type 1A diabetes. |
| TextSentencer_T4 |
278-306 |
Sentence |
denotes |
RESEARCH DESIGN AND METHODS: |
| T4 |
278-306 |
Sentence |
denotes |
RESEARCH DESIGN AND METHODS: |
| TextSentencer_T5 |
307-501 |
Sentence |
denotes |
We genotyped the +49G>A and CT60G>A variants of the CTLA4 gene in fulminant type 1 diabetic patients (n = 55), classic type 1A diabetic patients (n = 91), and healthy control subjects (n = 369). |
| T5 |
307-501 |
Sentence |
denotes |
We genotyped the +49G>A and CT60G>A variants of the CTLA4 gene in fulminant type 1 diabetic patients (n = 55), classic type 1A diabetic patients (n = 91), and healthy control subjects (n = 369). |
| TextSentencer_T6 |
502-570 |
Sentence |
denotes |
We also assessed serum levels of the soluble form of CTLA4 (sCTLA4). |
| T6 |
502-570 |
Sentence |
denotes |
We also assessed serum levels of the soluble form of CTLA4 (sCTLA4). |
| TextSentencer_T7 |
571-579 |
Sentence |
denotes |
RESULTS: |
| T7 |
571-579 |
Sentence |
denotes |
RESULTS: |
| TextSentencer_T8 |
580-661 |
Sentence |
denotes |
The +49GG and CT60GG genotypes were associated with type 1A diabetes (P < 0.001). |
| T8 |
580-661 |
Sentence |
denotes |
The +49GG and CT60GG genotypes were associated with type 1A diabetes (P < 0.001). |
| TextSentencer_T9 |
662-835 |
Sentence |
denotes |
In contrast, the CT60AA genotype, but not the +49G>A variation, was associated with fulminant type 1 diabetes (P < 0.05), especially in patients carrying HLA-DR4 (P < 0.01). |
| T9 |
662-835 |
Sentence |
denotes |
In contrast, the CT60AA genotype, but not the +49G>A variation, was associated with fulminant type 1 diabetes (P < 0.05), especially in patients carrying HLA-DR4 (P < 0.01). |
| TextSentencer_T10 |
836-942 |
Sentence |
denotes |
Serum levels of sCTLA4 were significantly decreased in patients with fulminant type 1 diabetes (P < 0.05). |
| T10 |
836-942 |
Sentence |
denotes |
Serum levels of sCTLA4 were significantly decreased in patients with fulminant type 1 diabetes (P < 0.05). |
| TextSentencer_T11 |
943-955 |
Sentence |
denotes |
CONCLUSIONS: |
| T11 |
943-955 |
Sentence |
denotes |
CONCLUSIONS: |
| TextSentencer_T12 |
956-1058 |
Sentence |
denotes |
These results suggest that CTLA4 CT60 affects the genetic susceptibility to fulminant type 1 diabetes. |
| T12 |
956-1058 |
Sentence |
denotes |
These results suggest that CTLA4 CT60 affects the genetic susceptibility to fulminant type 1 diabetes. |
| TextSentencer_T13 |
1059-1199 |
Sentence |
denotes |
Furthermore, the contribution of CTLA4 to disease susceptibility is distinct between fulminant type 1 diabetes and classic type 1A diabetes. |
| T13 |
1059-1199 |
Sentence |
denotes |
Furthermore, the contribution of CTLA4 to disease susceptibility is distinct between fulminant type 1 diabetes and classic type 1A diabetes. |